Uncategorized

Abbott India shares dip despite profit growth, CLSA adjusts rating

© Reuters.

Shares of Abbott India fell nearly 3 percent Today despite the company reporting a 17 percent year-on-year increase in net profit for the second quarter of fiscal year 2024. The healthcare company’s stock was traded on the National Stock Exchange (NSE) at Rs 23,197.05 this Saturday.

In its recent financial disclosure, Abbott India revealed an 8.31 percent rise in net sales to Rs 1,4914 crore for the quarter ending September 2023. Additionally, the firm experienced a significant 15.81 percent increase in EBITDA, which reached Rs 436.39 crore compared to the same period last fiscal year.

In response to these financial results, analysts at CLSA adjusted their stance on Abbott India’s stock. While they downgraded the rating to ‘outperform’ from ‘buy’, they simultaneously increased their price target for the shares to Rs 27,500 per share.

This mixed reaction from the market and analysts underscores the complex interplay between company performance metrics and investor expectations. Despite Abbott India’s strong profit and sales growth, the stock adjustment by CLSA suggests a recalibration of future performance projections and market positioning.

InvestingPro Insights

In a bid to provide a more comprehensive perspective on Abbott India’s performance, InvestingPro has surfaced some valuable insights. According to InvestingPro’s real-time data, Abbott India has a market cap of $139.49M USD and has been operating with a P/E ratio of -113.30. This suggests that the company’s shares are trading at a high price relative to its earnings, highlighting its current market valuation. Additionally, the company has experienced a revenue growth of 11.35% in the last twelve months as of Q3 2023, further indicating its strong financial position.

In terms of InvestingPro Tips, two key pointers stand out. Firstly, Abbott India yields a high return on invested capital, indicating efficient use of its resources to generate profits. Secondly, the company has consistently increased its earnings per share, pointing towards its ability to enhance shareholder value over time.

These insights are just a glimpse of what InvestingPro offers. With over 14 additional tips and extensive data available, InvestingPro serves as a reliable resource for investors seeking a deeper understanding of a company’s financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Crypto

FTX/Alameda has unstaked over $1 billion in Solana (SOL), raising concerns about potential market impact. Despite this, SOL remains resilient, trading near $137. However,...

News

Introduction One of the interesting elements of preferred shares in Canada is that some of the issues (and then predominantly preferred equity issued by...

Copyright © 2023 Repay Down. All Rights Reserved.

Exit mobile version